AACR meeting highlights new findings on drug resistance, targeted therapies

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|18|3259-3259

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.18, 2013-09, pp. : 3259-3259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Highlights from the AACR annual meeting

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2627-2627

John Wiley & Sons Inc

Access to resources Recommend Favorite

Highlights from the AACR International Conference

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 617-617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Resistance to Radiotherapy and Targeted Molecular Therapies in Squamous Cell Carcinomas of the Head and Neck, Preclinical Data and New Approaches

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 3, 2012-09 ,pp. : 254-264

Bentham Science Publishers

Access to resources Recommend Favorite

Somatic alterations as the basis for resistance to targeted therapies

By  

THE JOURNAL OF PATHOLOGY, Vol. 232, Iss. 2, 2014-01 ,pp. : 244-254

John Wiley & Sons Inc

Access to resources Recommend Favorite

Studies presented at ASCO meeting highlight success with targeted therapies

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2666-2667

John Wiley & Sons Inc

Access to resources Recommend Favorite